Cumberland Pharmaceuticals CPIX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's accrued expenses?
- Cumberland Pharmaceuticals (CPIX) reported accrued expenses of $12.98M in Q1 2026.
- How has Cumberland Pharmaceuticals's accrued expenses changed year-over-year?
- Cumberland Pharmaceuticals's accrued expenses increased by 15.7% year-over-year, from $11.22M to $12.98M.
- What is the long-term trend for Cumberland Pharmaceuticals's accrued expenses?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's accrued expenses has grown at a 2.3% compound annual growth rate (CAGR), from $11.25M to $12.64M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.